ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q4Scopus Q3SCImago #20,170Subscription

Pharmazie

Abbreviation (ISO):PHARMAZIE
•
Identifier (ISSN):0031-7144(Print)
•
Publisher:Govi-Verlag Pharmazeutischer Verlag GmbH
Clarivate IF (2026)
0.7↓ -0.3
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Pharmazie

WoS Q4
01231.0220180.8220191.220201.2720211.5120221.620231.52024120250.72026
Annual Impact Factor Metric
Current (2026):0.7
Scopus SJR & RankScopus Q3
0.231
#20,170

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
77

77 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessSubscription
106articles/year
0% Gold OA•100% Original Research

Aims & Scope

The journal DiePharmazie publishs reviews, experimental studies, letters to the editor, as well as book reviews. The following fields of pharmacy are covered: Pharmaceutical and medicinal chemistry; Pharmaceutical analysis and drug control; Pharmaceutical technolgy; Biopharmacy (biopharmaceutics, pharmacokinetics, biotransformation); Experimental and clinical pharmacology; Pharmaceutical biology (pharmacognosy); Clinical pharmacy; History of pharmacy.

Topics Covered (Recognized by AI)
Chemistry90.5%Biology83.2%Medicine70.5%Organic chemistry56.9%Biochemistry55.7%Genetics39.7%Pharmacology38.4%Internal medicine37.8%Physics35.4%Chromatography30.9%Materials science23%Endocrinology22.7%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

CHEMISTRY, MEDICINAL

Q4
Rank72/72
IndexSCIE
JCRSCIE2026

CHEMISTRY, MULTIDISCIPLINARY

Q4
Rank218/250
IndexSCIE
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q4
Rank333/356
IndexSCIE
JCISCIE2026

CHEMISTRY, MEDICINAL

Q4
Rank70/72
IndexSCIE
JCISCIE2026

CHEMISTRY, MULTIDISCIPLINARY

Q3
Rank184/251
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q4
Rank323/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF0.7
Articles / Year29
Total Citations2
2025
IF1
Articles / Year30
Total Citations6
2024
IF1.5
Articles / Year41
Total Citations31
2023
IF1.6
Articles / Year40
Total Citations57
2022
IF1.515
Articles / Year65
Total Citations179

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #20,170Scopus Q3SCImago Profile
Scopus Coverage:1947-2025
Scopus Broad Areas:Pharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q3
0.231

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
0.73

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,710 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations127
3-Year Documents146
Citable Documents146

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate32.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmaceutical ScienceQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区CHEMISTRY, MEDICINAL
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
In warning list
2022
Not warned
2023
In warning list
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Pharmazie (abbr: PHARMAZIE, ISSN: 0031-7144) is a peer-reviewed international scholarly journal in the field of Medicine, published by Govi-Verlag Pharmazeutischer Verlag GmbH in Germany since 1946. The periodical holds a Journal Impact Factor (JIF) of 0.70, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.231 (Q3), an H-index of 77.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 106 scientific articles. In terms of accessibility and author fees, it operates under the Subscription model with an estimated APC of $2,710 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Subscription
Publisher
Govi-Verlag Pharmazeutischer Verlag GmbH
Publication Language
Multi-Language
Frequency
Monthly
Founding Year
1946
Indexing & Databases
SCIEScopusPubMed
Editorial Address
GOVI-VERLAG PHARMAZEUTISCHER VERLAG GMBH, PHARMAZEUTISCCARL MANNICH STR 26, ESCHBORN, GERMANY, D-65760

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: cf912441-d7c8-4706-9a0c-f05a97db5964
Database Updated: 2026-10-01